Recombinant Sialyltransferase Infusion Mitigates Infection-Driven Acute Lung Inflammation
Inappropriate inflammation exacerbates a vast array of chronic and acute conditions with severe health risks. In certain situations, such as acute sepsis, traditional therapies may be inadequate in preventing severe organ damage or death. We have previously shown cell surface glycan modification by...
Main Authors: | Mehrab Nasirikenari, Amit A. Lugade, Sriram Neelamegham, Zhongwei Gao, Kelley W. Moremen, Paul N. Bogner, Yasmin Thanavala, Joseph T. Y. Lau |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-02-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fimmu.2019.00048/full |
Similar Items
-
Systemic ST6Gal-1 Is a Pro-survival Factor for Murine Transitional B Cells
by: Eric E. Irons, et al.
Published: (2018-09-01) -
The Role of Sialyl-Tn in Cancer
by: Jennifer Munkley
Published: (2016-02-01) -
Importance des glycoconjugués périphériques dans la différenciation myogénique : Rôle particulier de l'Ω (2,6) sialylation
by: Bouchatal, Amel
Published: (2015) -
Significance of β-Galactoside α2,6 Sialyltranferase 1 in Cancers
by: Jishun Lu, et al.
Published: (2015-04-01) -
Engineering of CHO cells for the production of vertebrate recombinant sialyltransferases
by: Benoit Houeix, et al.
Published: (2019-02-01)